Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from AIM Vaccine Co., Ltd. Class H ( (HK:6660) ) is now available.
AIM Vaccine Co., Ltd. has announced changes in the composition of its board committees following the resignation of two directors. The company has restructured its Audit, Nomination, Remuneration and Appraisal, Strategy, and Compliance and Risk Control Committees to enhance its governance structure, which is expected to support its continuous development and ensure compliance with relevant listing rules.
More about AIM Vaccine Co., Ltd. Class H
AIM Vaccine Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biotechnology sector with a focus on vaccine development and production.
YTD Price Performance: -47.72%
Average Trading Volume: 6,404,183
Technical Sentiment Signal: Buy
For detailed information about 6660 stock, go to TipRanks’ Stock Analysis page.